Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agencies-Reference-Cited by-同舟云学术

Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agencies

Published:2014-03 Issue:14 Volume:32 Page:1624-1629
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Dodet Betty

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference61 articles.

1. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines;Gottlieb;Vaccine,2014

2. The vaccine industry;Douglas,2012

3. The vaccine industry – an overview;Prifti C,2013

4. The history of vaccines;College of Physicians of Philadelphia,2013

5. European Vaccine Initiative (EVI). Stages of vaccine development, .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs;Microorganisms;2024-06-13

2. Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model;Frontiers in Immunology;2022-11-23

3. Strategies for successful designing of immunocontraceptive vaccines and recent updates in vaccine development against sexually transmitted infections - A review;Saudi Journal of Biological Sciences;2022-04

4. Advancing Prevention of STIs by Developing Specific Serodiagnostic Targets: Trichomonas vginalis as a Model;International Journal of Environmental Research and Public Health;2020-08-10

5. Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019;Vaccine;2020-06